Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers are increasingly used in clinical practice for the diagnosis of Alzheimer's disease (AD). We aimed to 1) determine cutoff values of CSF biomarkers for AD, 2) investigate their clinical utility by estimating a concordance with amyloid positron emi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Korean Med Sci
Autors principals: Lee, Jongmin, Jang, Hyemin, Kang, Sung Hoon, Kim, Jaeho, Kim, Ji Sun, Kim, Jun Pyo, Kim, Hee Jin, Seo, Sang Won, Na, Duk L.
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7669457/
https://ncbi.nlm.nih.gov/pubmed/33200589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e361
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars